Currently Recruiting Clinical Trials

Find clinical trials that are currently recruiting participants. AI-powered trial analysis in plain English with decoded eligibility criteria.

A Phase 3b/4 Multi-center, Randomized, Open-label, Long-term Safety Study of Deucravacitinib in Comparison to Ustekinumab in Participants With Moderate-to-Severe Plaque Psoriasis

NCT07116967 · RECRUITING · Phase 3 · Bristol-Myers Squibb

Planned vs. Actual Acetabular Cup Position in Total Hip Arthroplasty With Non-Invasive Navigation

NCT06631638 · RECRUITING · N/A · DePuy Orthopaedics

St. Jude Autologous Genome Edited Stem Cells For Sickle Cell Disease-1

NCT06506461 · RECRUITING · Phase 1 · St. Jude Children's Research Hospital

Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (Tocilizumab) for the Treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma

NCT05233397 · RECRUITING · Phase 2 · Nationwide Children's Hospital

A Phase 1a/1b Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BBO-10203 in Subjects With Advanced Solid Tumors (The BREAKER-101 Study)

NCT06625775 · RECRUITING · Phase 1 · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, 24-Week Study With Additional 24-Week Blinded Active Extension to Evaluate the Safety and Efficacy of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

NCT07161999 · RECRUITING · Phase 2 · Coya Therapeutics

Randomized Phase III Trial of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma (C-PRE)

NCT06568172 · RECRUITING · Phase 3 · National Cancer Institute (NCI)

Phase 1B/2A Study of CTO1681 for the Prevention and Treatment of Cytokine Release Syndrome in Patients With Diffuse Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy

NCT05905328 · RECRUITING · Phase 2 · CytoAgents, Inc.

A Multicenter, Randomized, Double-Blind, Exploratory Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

NCT07147114 · RECRUITING · Phase 4 · Gachon University Gil Medical Center

A Phase 1a, Open-Label, First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of KT501 by a Single Subcutaneous Administration in Participants With Rheumatoid Arthritis

NCT07234773 · RECRUITING · Phase 1 · Kali Therapeutics, Inc.

Biospecimen Acquisition From Human Subjects

NCT00034216 · RECRUITING · N/A · National Cancer Institute (NCI)

RECOVER-HF - RandomizEd, Multi-Center, Double-Blinded Study of SynchrOnized Diaphragmatic Stimulation (SDS) for ImproVEment of Symptomatic Reduced Ejection Fraction Heart Failure

NCT06552637 · RECRUITING · N/A · VisCardia Inc.

A Prospective Multicenter Single Arm Study to Assess the Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System for the Treatment of Subjects With Atherosclerotic Lesion(s)

NCT06779630 · RECRUITING · N/A · Teleflex

Characterisation of phenotYpes in aCute Heart faiLure patiEnts

NCT07508891 · RECRUITING · N/A · Universitätsklinikum Hamburg-Eppendorf

A Prospective, Randomized, Multicenter, International, Open-Label Clinical Trial Comparing Drug-Coated Balloon and Drug-Eluting Stent for the Treatment of Acute ST-Elevation Myocardial Infarction.

NCT06746233 · RECRUITING · N/A · Institute of Cardiovascular Diseases, Vojvodina

The Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques: An Investigator-Blinded Study

NCT02784210 · RECRUITING · Phase 2 · National Institute of Neurological Disorders and Stroke (NINDS)

Comparison of the Performance of the 2024 and 2017 McDonald Criteria for the Diagnosis of Multiple Sclerosis in Real Life

NCT07492667 · RECRUITING · N/A · Central Hospital, Nancy, France

A Phase IIa Double-Blind, Randomized, Parallel-Arm, Placebo-Controlled Trial To Investigate The Effects Of Three Dose Levels Of CIT-013 On Disease Activity In Patients With Moderately Active Rheumatoid Arthritis.

NCT06567470 · RECRUITING · Phase 2 · Citryll BV

Find Trials by Condition

Search for specific conditions or browse by trial phase.